查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594379

多组体学市场：按产品类型、应用和最终用户划分 - 2025-2030 年全球预测

Multiomics Market by Product (Consumables, Instrument, Software), Type (Epigenomics, Genomics, Metabolomics), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年多组体学市场价值为835.5亿美元，预计到2024年将达到968.6亿美元，复合年增长率为16.26%，到2030年将达到2399.2亿美元。

多体学是生物研究领域的综合办法，它整合了基因组学、转录组学、蛋白质组学和代谢体学等多种「体学」技术，以全面了解细胞、组织和生物体的分子组成。对多组体学的需求源于生物系统的复杂性以及了解不同分子成分如何相互作用以及如何影响健康和疾病状态的需要。应用范围广泛，包括个人化医疗、生物标记发现、药物开发和农业。

主要市场统计
基准年[2023] 835.5亿美元
预测年份 [2024] 968.6亿美元
预测年份 [2030] 2399.2亿美元
复合年增长率（%） 16.26%

研究范围包括製药和生物技术公司、研究机构、医院和诊所。多体学在药物发现和治疗开发中发挥关键作用，可以实现更有针对性的治疗和个人化治疗计划，并且对精准医学的进步至关重要。此外，它还有助于农业生物技术，改善作物育种和提高抵御能力，为粮食安全做出重大贡献。

促进市场开拓的因素包括体学技术的进步、研发投资的增加、慢性病的流行以及对个人化医疗的日益重视。对精准医疗、新兴市场不断增长的需求以及多组体学资料和人工智慧的整合以增强分析可以找到关键机会。学术机构和生技公司之间不断加强的伙伴关係也可能产生巨大的推动作用。

然而，市场成长面临挑战，例如与体学技术相关的高成本、复杂的资料解释以及对先进生物资讯学专业知识的需求。隐私问题和监管限制使研究和应用更加复杂。

创新和研究可以集中在开发更具成本效益和可扩展的体学技术、改进资料整合方法以及增强生物资讯学工具以更好地进行资料分析。这些细分市场的最佳化预计将解决现有挑战并促进市场扩张。儘管市场竞争激烈，但透过关注系统生物学等新兴领域、促进跨部门合作、汇集专业知识和利用新兴技术，仍存在巨大的成长潜力。

市场动态：揭示快速发展的多组体学市场的关键市场洞察

供给和需求的动态交互作用正在改变多组体学市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • NGS、基于质谱的蛋白质组学和基因表现平台的不断进步
    • 由于对个人化医疗的日益偏好，潜力巨大
    • 活性化生物技术公司的研究和开发
  • 市场限制因素
    • 与多组体学相关的高成本且专家技术有限
  • 市场机会
    • 加强先进技术与多组体学的整合
    • 增加对农业研究和环境科学的投资以实现永续性目标
  • 市场问题
    • 体学研究中资料收集、储存和共用的标准通讯协定有限

波特的五力：驾驭体学市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点，避免潜在的挑战，确保更强大的市场地位。

PESTLE分析：了解多组体学市场的外部影响

外部宏观环境因素在塑造多组体学市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解多体学市场的竞争格局

对多组体学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：多体学市场供应商的绩效评估

FPNV定位矩阵是评估多组体学市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製多体学市场的成功之路

多组体学市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • NGS、质谱特异性蛋白质体学和基因表现平台的进展
      • 由于对个人化药物的日益偏好，潜力巨大
      • 生技公司的研发活动增加
    • 抑制因素
      • 与多组体学相关的高成本且专家技术有限
    • 机会
      • 扩大先进技术与多组体学的整合
      • 增加对农业研究和环境科学的投资以实现永续性目标
    • 任务
      • 体学研究中资料收集、储存和共用的标准通讯协定有限
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章 多组体学市场：副产品

  • 介绍
  • 消耗品
  • 装置
  • 软体

第 7 章 多组体学市场：按类型

  • 介绍
  • 表观基因
  • 基因组学
  • 代谢体学
  • 微生物组学
  • 蛋白质体学
  • 转录组学

第 8 章 多组体学市场：依应用分类

  • 介绍
  • 农业和植物科学
  • 诊断
  • 药物发现
  • 精准医疗

第 9 章 多组体学市场：依最终使用者划分

  • 介绍
  • 学术研究所
  • 生技公司
    • 农业
    • 环境科学
    • 法医学
    • 植物和动物育种
  • 医院/诊所
  • 製药和生物製药公司

第10章美洲多组体学市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太多组体学市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的多组体学市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • MultiOmic Health 完成 620 万美元资金筹措，用于开发METABOLIC INC.症候群相关疾病的精准药物
    • Biomodal 宣布新的多组体学定序技术
    • Tempus 宣布与 Actuate Therapeutics 开展新的多组体学合作
    • BD 推出高性能单细胞多组体学平台以扩大科学发现的范围
  • 战略分析和建议

公司名单

  • 10x Genomics, Inc.
  • AstraZeneca PLC
  • Becton, Dickinson and Company
  • Berkeley Lights, Inc.
  • BGI Genomics Co. Ltd
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc. by PerkinElmer, Inc.
  • Celsee
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Dolomite Bio by Unchained Labs
  • EpiCypher, Inc.
  • Google LLC by Alphabet Inc.
  • Illumina, Inc.
  • Miltenyi BIoTec
  • Mission Bio, Inc.
  • Multiomic Health Limited
  • NanoCellect Biomedical
  • NanoString Technologies, Inc.
  • Novo Nordisk A/S
  • Olink Proteomics AB
  • QIAGEN NV
  • Shimadzu Corporation
  • Singleron BIoTechnologies GmbH
  • Standard BioTools Inc.
  • TAKARA BIO INC.
  • Tempus Labs, Inc.
  • Thermo Fischer Scientific Inc.
Product Code: MRR-CF699CF41428

The Multiomics Market was valued at USD 83.55 billion in 2023, expected to reach USD 96.86 billion in 2024, and is projected to grow at a CAGR of 16.26%, to USD 239.92 billion by 2030.

Multiomics is a comprehensive approach within the field of biological research that integrates multiple "omics" technologies, such as genomics, transcriptomics, proteomics, and metabolomics, to provide an all-encompassing view of the molecular constituents of cells, tissues, and organisms. The necessity of multiomics arises from the complex nature of biological systems and the need to understand how different molecular components interact and contribute to health and disease states. Its applications span personalized medicine, biomarker discovery, drug development, and agriculture.

KEY MARKET STATISTICS
Base Year [2023] USD 83.55 billion
Estimated Year [2024] USD 96.86 billion
Forecast Year [2030] USD 239.92 billion
CAGR (%) 16.26%

The end-use scope includes pharmaceuticals, biotechnology companies, research institutions, hospitals, and clinics. Multiomics has proven essential for advancing precision medicine, allowing for more targeted therapies and personalized treatment plans, while playing a pivotal role in drug discovery and therapeutic development. Moreover, it helps in agricultural biotechnology by enhancing crop breeding and resilience, contributing significantly to food security.

Market growth factors include advancements in omics technologies, increased investment in research and development, the prevalence of chronic diseases, and a growing emphasis on personalized healthcare. Key opportunities can be found in the rising demand for precision medicine, emerging markets, and the integration of artificial intelligence with multiomics data for enhanced analytics. Expanding partnerships between academic institutions and biotechnology firms could also offer a significant boost.

However, market growth faces challenges such as high costs associated with omics technologies, complex data interpretation, and the need for high-level bioinformatics expertise. Privacy concerns and regulatory constraints further complicate multiomics research and application.

Innovation and research could focus on developing more cost-effective and scalable omics technologies, improving data integration methods, and enhancing bioinformatics tools for better data analysis. Optimizing these areas would address existing challenges and drive market expansion. Despite the competitive nature of the market, there remains potential for significant growth by focusing on emerging fields such as systems biology and by fostering collaborations across sectors to harness collective expertise and leverage emerging technologies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Multiomics Market

The Multiomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
    • High potential owing to a growing preference towards personalized medicines
    • Rising research & development activities conducted by biotechnology companies
  • Market Restraints
    • High cost and limited skilled professionals associated with multiomics
  • Market Opportunities
    • Growing integration of advanced technologies into multiomics
    • Increasing investments in agriculture research and environmental science with sustainability targets
  • Market Challenges
    • Limited standard protocols for data acquisition, storage, and sharing across omics studies

Porter's Five Forces: A Strategic Tool for Navigating the Multiomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Multiomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Multiomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Multiomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Multiomics Market

A detailed market share analysis in the Multiomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Multiomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Multiomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Multiomics Market

A strategic analysis of the Multiomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Multiomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., AstraZeneca PLC, Becton, Dickinson and Company, Berkeley Lights, Inc., BGI Genomics Co. Ltd, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioLegend, Inc. by PerkinElmer, Inc., Celsee, Charles River Laboratories International, Inc., Danaher Corporation, Dolomite Bio by Unchained Labs, EpiCypher, Inc., Google LLC by Alphabet Inc., Illumina, Inc., Miltenyi Biotec, Mission Bio, Inc., Multiomic Health Limited, NanoCellect Biomedical, NanoString Technologies, Inc., Novo Nordisk A/S, Olink Proteomics AB, QIAGEN N.V., Shimadzu Corporation, Singleron Biotechnologies GmbH, Standard BioTools Inc., TAKARA BIO INC., Tempus Labs, Inc., and Thermo Fischer Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Multiomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables, Instrument, and Software.
  • Based on Type, market is studied across Epigenomics, Genomics, Metabolomics, Microbiomics, Proteomics, and Transcriptomics.
  • Based on Application, market is studied across Agriculture & Plant Science, Diagnostics, Drug Discovery, and Precision Medicine.
  • Based on End-User, market is studied across Academic & Research Institutes, Biotechnology Companies, Hospitals & Clinics, and Pharmaceutical & Biopharmaceutical Companies. The Biotechnology Companies is further studied across Agriculture, Environmental Science, Forensics, and Plant & Animal Breeding.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing advancements in NGS, mass spectrometry-based proteomics, and gene expression profiling platforms
      • 5.1.1.2. High potential owing to a growing preference towards personalized medicines
      • 5.1.1.3. Rising research & development activities conducted by biotechnology companies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and limited skilled professionals associated with multiomics
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing integration of advanced technologies into multiomics
      • 5.1.3.2. Increasing investments in agriculture research and environmental science with sustainability targets
    • 5.1.4. Challenges
      • 5.1.4.1. Limited standard protocols for data acquisition, storage, and sharing across omics studies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Multiomics Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instrument
  • 6.4. Software

7. Multiomics Market, by Type

  • 7.1. Introduction
  • 7.2. Epigenomics
  • 7.3. Genomics
  • 7.4. Metabolomics
  • 7.5. Microbiomics
  • 7.6. Proteomics
  • 7.7. Transcriptomics

8. Multiomics Market, by Application

  • 8.1. Introduction
  • 8.2. Agriculture & Plant Science
  • 8.3. Diagnostics
  • 8.4. Drug Discovery
  • 8.5. Precision Medicine

9. Multiomics Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology Companies
    • 9.3.1. Agriculture
    • 9.3.2. Environmental Science
    • 9.3.3. Forensics
    • 9.3.4. Plant & Animal Breeding
  • 9.4. Hospitals & Clinics
  • 9.5. Pharmaceutical & Biopharmaceutical Companies

10. Americas Multiomics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Multiomics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Multiomics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. MultiOmic Health Closes USD 6.2 Million Funding Round to Discover Precision Medicines for Metabolic Syndrome-Related Conditions
    • 13.3.2. Biomodal Launches New Multiomics Sequencing Technology
    • 13.3.3. Tempus Announces New Multi-omics Collaboration with Actuate Therapeutics
    • 13.3.4. BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. AstraZeneca PLC
  • 3. Becton, Dickinson and Company
  • 4. Berkeley Lights, Inc.
  • 5. BGI Genomics Co. Ltd
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Bio-Techne Corporation
  • 8. BioLegend, Inc. by PerkinElmer, Inc.
  • 9. Celsee
  • 10. Charles River Laboratories International, Inc.
  • 11. Danaher Corporation
  • 12. Dolomite Bio by Unchained Labs
  • 13. EpiCypher, Inc.
  • 14. Google LLC by Alphabet Inc.
  • 15. Illumina, Inc.
  • 16. Miltenyi Biotec
  • 17. Mission Bio, Inc.
  • 18. Multiomic Health Limited
  • 19. NanoCellect Biomedical
  • 20. NanoString Technologies, Inc.
  • 21. Novo Nordisk A/S
  • 22. Olink Proteomics AB
  • 23. QIAGEN N.V.
  • 24. Shimadzu Corporation
  • 25. Singleron Biotechnologies GmbH
  • 26. Standard BioTools Inc.
  • 27. TAKARA BIO INC.
  • 28. Tempus Labs, Inc.
  • 29. Thermo Fischer Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. MULTIOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. MULTIOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MULTIOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MULTIOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MULTIOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MULTIOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MULTIOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MULTIOMICS MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MULTIOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MULTIOMICS MARKET SIZE, BY EPIGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MULTIOMICS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MULTIOMICS MARKET SIZE, BY METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MULTIOMICS MARKET SIZE, BY MICROBIOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MULTIOMICS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MULTIOMICS MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE & PLANT SCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MULTIOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MULTIOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MULTIOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MULTIOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL MULTIOMICS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL MULTIOMICS MARKET SIZE, BY ENVIRONMENTAL SCIENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL MULTIOMICS MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL MULTIOMICS MARKET SIZE, BY PLANT & ANIMAL BREEDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL MULTIOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL MULTIOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES MULTIOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA MULTIOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM MULTIOMICS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 242. MULTIOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 243. MULTIOMICS MARKET, FPNV POSITIONING MATRIX, 2023